Keywords: achillion, granted, patent, ns4a, antagonist, hep, pharmaceuticals

Achillion granted US patent for NS4A antagonist in hep C

Article | 17 April 2009

Achillion Pharmaceuticals, a US firm focused on the discovery and development of small-molecule drugs to combat the most challenging infectious ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Gilead Sciences

Giliad Sciences

Go to company listing